Literature DB >> 14593597

Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study.

Wilma A Stolk1, Subramanian Swaminathan, Gerrit J van Oortmarssen, P K Das, J Dik F Habbema.   

Abstract

LYMFASIM, a microsimulation model for transmission and control of lymphatic filariasis, was used to simulate the effects of mass treatment, in order to estimate the number of treatment rounds necessary to achieve elimination. Simulations were performed for a community that represented Pondicherry, India, and that had an average precontrol microfilariae (MF) prevalence of 8.5%. When ivermectin was used, 8 yearly treatment rounds with 65% population coverage gave a 99% probability of elimination. The number of treatment rounds necessary to achieve elimination depended to a large extent on coverage, drug efficacy, and endemicity level. Changing the interval between treatment rounds mainly influenced the duration of control, not the number of treatment rounds necessary to achieve elimination. Results hardly changed with alternative assumptions regarding the type of immune mechanism. The potential impact of mass treatment with a combination of diethylcarbamazine and albendazole is shown under different assumptions regarding its efficacy. Human migration and drug resistance were not considered. Results cannot be directly generalized to areas with different vector or epidemiological characteristics. In conclusion, the prospects for elimination of bancroftian filariasis by mass treatment in Pondicherry seem good, provided that the level of population coverage is sufficiently high.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14593597     DOI: 10.1086/378354

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  42 in total

1.  Wolbachia in filarial parasites: targets for filarial infection and disease control.

Authors:  Kelly L Johnston; Mark J Taylor
Journal:  Curr Infect Dis Rep       Date:  2007-01       Impact factor: 3.725

2.  Unfulfilled potential: using diethylcarbamazine-fortified salt to eliminate lymphatic filariasis.

Authors:  Patrick Lammie; Trevor Milner; Robin Houston
Journal:  Bull World Health Organ       Date:  2007-07       Impact factor: 9.408

3.  Global elimination of lymphatic filariasis: addressing the public health problem.

Authors:  David G Addiss
Journal:  PLoS Negl Trop Dis       Date:  2010-06-29

4.  The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007).

Authors:  Brian K Chu; Pamela J Hooper; Mark H Bradley; Deborah A McFarland; Eric A Ottesen
Journal:  PLoS Negl Trop Dis       Date:  2010-06-01

5.  Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs.

Authors:  Paul T Cantey; Jonathan Rout; Grace Rao; John Williamson; LeAnne M Fox
Journal:  PLoS Negl Trop Dis       Date:  2010-06-29

6.  Different mechanisms for heterogeneity in leprosy susceptibility can explain disease clustering within households.

Authors:  Egil Fischer; Sake De Vlas; Abraham Meima; Dik Habbema; Jan Richardus
Journal:  PLoS One       Date:  2010-11-19       Impact factor: 3.240

7.  Insecticidal bed nets and filariasis transmission in Papua New Guinea.

Authors:  Lisa J Reimer; Edward K Thomsen; Daniel J Tisch; Cara N Henry-Halldin; Peter A Zimmerman; Manasseh E Baea; Henry Dagoro; Melinda Susapu; Manuel W Hetzel; Moses J Bockarie; Edwin Michael; Peter M Siba; James W Kazura
Journal:  N Engl J Med       Date:  2013-08-22       Impact factor: 91.245

8.  Post-Mass Drug Administration Transmission Assessment Survey for Elimination of Lymphatic Filariasis in La Ciénaga, Dominican Republic.

Authors:  Gregory S Noland; Stephen Blount; Manuel Gonzalez
Journal:  Am J Trop Med Hyg       Date:  2015-10-26       Impact factor: 2.345

Review 9.  Filariasis and lymphoedema.

Authors:  K M Pfarr; A Y Debrah; S Specht; A Hoerauf
Journal:  Parasite Immunol       Date:  2009-11       Impact factor: 2.280

10.  Endpoints for lymphatic filariasis programs.

Authors:  Caroline A Grady; Madsen Beau de Rochars; Abdel N Direny; Jean Nicolas Orelus; Joyanna Wendt; Jeanne Radday; Els Mathieu; Jacquelin M Roberts; Thomas G Streit; David G Addiss; Patrick J Lammie
Journal:  Emerg Infect Dis       Date:  2007-04       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.